Asset Management One Co. Ltd. trimmed its position in shares of Danaher Corporation (NYSE:DHR) by 0.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,040,951 shares of the conglomerate’s stock after selling 4,228 shares during the period. Asset Management One Co. Ltd. owned approximately 0.15% of Danaher worth $89,217,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. GQG Partners LLC acquired a new stake in Danaher during the 2nd quarter valued at $101,000. Proficio Capital Partners LLC grew its holdings in Danaher by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares in the last quarter. Monetary Management Group Inc. boosted its stake in Danaher by 10.7% during the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after acquiring an additional 150 shares during the last quarter. Acrospire Investment Management LLC boosted its stake in Danaher by 185.5% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after acquiring an additional 1,100 shares during the last quarter. Finally, Motco boosted its stake in Danaher by 8.8% during the 2nd quarter. Motco now owns 2,011 shares of the conglomerate’s stock valued at $170,000 after acquiring an additional 163 shares during the last quarter. 76.32% of the stock is owned by institutional investors and hedge funds.

Danaher Corporation (NYSE:DHR) opened at $93.18 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a 52-week low of $77.45 and a 52-week high of $94.82. The stock has a market cap of $64,468.69, a PE ratio of 23.83, a PEG ratio of 2.20 and a beta of 1.02.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same period last year, the firm posted $0.87 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. research analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%. Danaher’s payout ratio is currently 16.52%.

In other news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total value of $11,671,620.96. Following the transaction, the chief executive officer now directly owns 271,737 shares in the company, valued at approximately $25,173,715.68. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Daniel Raskas sold 37,870 shares of the firm’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 273,810 shares of company stock worth $25,218,813. Insiders own 12.20% of the company’s stock.

A number of research firms have commented on DHR. Cowen reiterated a “buy” rating and set a $90.00 price objective on shares of Danaher in a research note on Wednesday, October 4th. Morgan Stanley reiterated an “overweight” rating and set a $95.00 price objective (up from $86.00) on shares of Danaher in a research note on Friday, October 6th. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Robert W. Baird increased their price objective on shares of Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price objective on shares of Danaher in a research note on Friday, September 8th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Danaher has an average rating of “Buy” and an average price target of $93.31.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/12/09/danaher-corporation-dhr-position-trimmed-by-asset-management-one-co-ltd.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.